Brief: PegBio Says China NMPA Approves NDA For PB-119
14/11/2025 10:28
Nov 14 (Reuters) - PegBio Co Ltd 2565.HK: CHINA NMPA APPROVES NDA FOR PB-119 Further company coverage: 2565.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pegbio
See all newsBrief: Pegbio Enters Joint Research And Development Collaboration With SN Bioscience
Brief: Alibaba Health Inks Strategic Tie-Up With Tenry, PegBio To Launch GLP-1RA Drug
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: PegBio Co Posts FY Loss Attributable RMB208.4 Million
PegBio jumps most in 7 months on deal with Shanghai Tenry